Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration …

Objectives To evaluate the clinical outcomes of persistent radioiodine uptake (RAIU) in the
neck by diagnostic whole body scan (DxWBS) after initial therapy and the efficacy of the …

Purpose In DTC patients, 131-radioiodine therapy has routinely been used for many years
for thyroid remnant ablation after thyroid surgery. To date, two different strategies can be …

Results When three tests were used to define successful ablation, in group L, 32 out of 53
(60%) and 43 out of 53 (81%) patients were successfully treated versus 35 out of 55 (64%) …

Objective Recent guidelines for surveillance of patients with differentiated thyroid carcinoma
emphasize TSH‐stimulated serum thyroglobulin (Tg) measurements and neck …

Context: Thyroglobulin (Tg) levels measured at the time of remnant ablation after thyroid
hormone withdrawal (THW) were shown to have prognostic value in predicting disease-free …

Background Achieving an undetectable serum thyroglobulin (Tg) level (< 1.0 ng/mL) after
surgical and radioiodine treatment for papillary thyroid cancer (PTC) is associated with low …

Background: At present, empirical radioactive iodine therapy is recommended for patients
with thyroid cancer and elevated thyroglobulin (Tg) after initial therapy when neck …

Objectives: The rate and impact of thyroglossal duct remnant (TGDR) visualization in
patients with hypothyroidism after total thyroidectomy for differentiated thyroid carcinoma …

Introduction Low-risk differentiated thyroid cancer (DTC) is currently rarely treated with
radioiodine (131I) to ablate the postoperative remnant. Therefore, the interpretation of the …